Antiseizure medications and challenges in the COVID-19 pandemic – focus on drug interactions

During the COVID19 pandemic crisis we receive a number of questions on anti-seizure drug interactions.

The ERN EpiCARE working group on Education and Training invited a panel of experts in Clinical Pharmacology and/or on Treatment of Status Epilepticus, and members of EpiCARE, to share their experience on this very challenging topic.

Register

Register here

Members of the panel

Professor Cecilie Landmark (Oslo, NORWAY)
Professor Emilio Perucca (Pavia, ITALY)
Professor Eugen Trinka(Salzburg, AUSTRIA)
Professor Simon Shorvon (London, UK)